Cargando…
Viekira Pak Induced Fatal Lactic Acidosis: A Case Report of an Unusual Side Effect
Viekira Pak is a new direct-acting antiviral agent that has an excellent efficacy in treating patients with chronic HCV. FDA released a safety warning that Viekira Pak can cause serious liver injury mostly in patients with underlying advanced liver disease. We report the first case of fatal lactic a...
Autores principales: | Abdulsamad, Molham, Ihimoyan, Ariyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156790/ https://www.ncbi.nlm.nih.gov/pubmed/28044114 http://dx.doi.org/10.1155/2016/8627139 |
Ejemplares similares
-
VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature
por: Wong, Yu Jun, et al.
Publicado: (2019) -
Drug Induced Pneumonitis Secondary to Treatment with Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction
por: Wu, Shih Yea Sylvia, et al.
Publicado: (2017) -
Fatal Tenofovir-Associateacd Lactic Acidosis: A Case Report
por: Hashim, Hasriza, et al.
Publicado: (2015) -
Systemic vascular resistance in cirrhosis: a predictor of severity?
por: Gaduputi, Vinaya, et al.
Publicado: (2014) -
An Unusual Case of Rectal and Ileal Carcinoid Tumors
por: Abdulsamad, Molham, et al.
Publicado: (2017)